STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence
Science Advances · 09.01.2026 · 12 (2)
DOI: 10.1126/sciadv.adx9671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 09.01.2026. Verfasst von Qi Shang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China. Hauptthemen laut MEDLINE: Glioblastoma, Prodrugs, Hydrogels, Membrane Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM), the most aggressive primary brain tumor, demonstrates persistent resistance to immunotherapy due to its profoundly immunosuppressive microenvironment and markedly limited T cell infiltration. In this context, we engineered a STING agonist–incorporated prodrug hydrogel that orchestrates dual activation of innate and adaptive immunity to prevent postoperative GBM recurrence. We found that this in situ–forming hydrogel integrates seamlessly with tumor resection procedures, serves as a drug depot for sustained tumoral releases of therapeutic agents, and thus reprograms the tumor microenvironment by promoting M1 macrophage polarization, suppressing regulatory T cell activity, and enhancing cytotoxic T lymphocyte infiltration, thereby establishing a robust antitumor immune response. As a postoperative adjuvant therapy, the hydrogel effectively inhibits orthotopic GBM recurrence and extends animal survival while establishing durable immune memory against tumor rechallenge. Our findings demonstrate the translational potential of immunologically engineered hydrogels for STING-activated immunotherapy in preventing postresection GBM recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China.
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China.
- Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, PR China.
ORCID-Profile: Qi Shang, Chenwei Jiang, Qiang Zhang, Feihu Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
- Key project at central government level
- Shanghai Jiao Tong University
- Zhejiang Key Laboratory of Blood-Stasis-Toxin Syndrome
Zitieren
APA
Shang, Q., Jiang, C., Guo, M., Tang, M., Yang, J., Xie, J., An, X., Zhang, Q., & Wang, F. (2026). STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence. Science Advances, 12(2). https://doi.org/10.1126/sciadv.adx9671
Vancouver
Shang Q, Jiang C, Guo M, Tang M, Yang J, Xie J, et al. STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence. Science Advances. 2026;12(2). doi:10.1126/sciadv.adx9671
BibTeX
@article{Shang2026,
author = {Shang, Qi and Jiang, Chenwei and Guo, Mingmei and Tang, Minglu and Yang, Jiapei and Xie, Junjie and An, Xiaoran and Zhang, Qiang and Wang, Feihu},
title = {STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {2},
doi = {10.1126/sciadv.adx9671}
}
EUVIMED